• Bharat Biotech’s intranasal Covid vaccine, BBV154, has been approved by the Drugs Controller General of India for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
• The vaccine will be available to the public through the CO-WIN platform.
[Via]
